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Highlights 
 Translational studies of mitochondrial lipid changes in GWI. 
 Long-term memory deficits are present in a GWI mouse model 
 Mitochondrial lipids are decreased in the brains of a GWI mouse model. 
 Plasma mitochondrial lipids are decreased in a GWI mouse and in veterans with GWI. 
 Targeting mitochondria may be useful for developing GWI therapies and biomarkers.  
 
Abstract: 
Gulf War Illness (GWI) affects 25% of veterans from the 1990-1991 Gulf War (GW) and is 
accompanied by damage to the brain regions involved in memory processing. After twenty-five years, 
the chronic pathobiology of GWI is still unexplained. To address this problem, we examined the long-
term consequences of GW exposures in an established GWI mouse model to identify biological 
processes that are relevant to the chronic symptoms of GWI.  Three-month old male C57BL6 mice 
were exposed for 10 days to GW agents (pyridostigmine bromide and permethrin).  Barnes Maze 
testing conducted at 15- and 16-months post-exposure revealed learning and memory impairment. 
Immunohistochemical analyses showed astroglia and microglia activation in the hippocampi of 
exposed mice. Proteomic studies identified perturbation of mitochondria function and metabolomics 
data showed decreases in the Krebs cycle compounds, lactate, β-hydroxybutyrate and glycerol-3 
phosphate in the brains of exposed mice.  Lipidomics data showed decreases in fatty acids, 
acylcarnitines and phospholipids, including cardiolipins in the brains of exposed mice.  Pilot biomarker 
studies showed that plasma from exposed mice and veterans with GWI had increases in odd-chain, 
and decreases in long-chain, acylcarnitines compared to their respective controls. Very long-chain 
acylcarnitines were decreased in veterans with GWI compared to controls. These studies suggest 
that mitochondrial lipid disturbances might be associated with GWI and that further investigation is 
required to determine its role in the pathophysiology of this illness.  Targeting mitochondrial function 
may provide effective therapies for GWI, and that lipid abnormalities could serve as biomarkers of 
GWI.  
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1. Introduction: 
 Nearly 250,000 veterans from the 1990-1991 Gulf War (GW) continue to suffer from Gulf War 
Illness (GWI), which is a chronic and debilitating condition with a central nervous system (CNS) 
component (White et al., 2016; Binns et al., 2008) that is characterized by reduced volume and 
hypometabolism in the hippocampi of veterans with GWI (White et al., 2016).  A functional imaging 
study showed that deficits in working memory are associated with an abnormal activation of the 
prefrontal cortex of ill GW veterans (Hubbard et al., 2014).  A diffusion tensor imaging study 
suggested that compared to controls, veterans with GWI have atrophy of the axonal tracts that link 
the cortical gray matter regions involved in fatigue, pain and cognition (Rayhan et al., 2013b).  
Current treatments for GWI are based on symptom management due to a lack of understanding of 
the complex pathophysiology of GWI.  Many GW veterans have not been able to receive an 
appropriate diagnosis of their conditions due to the unavailability of objective biological markers that 
can quantify the underlying pathology.  Hence, investigations into chronic pathophysiology of GWI is 
required for developing treatments and diagnostic biomarkers of this illness.   
 Reports compiled by the Research Advisory Committee (RAC) on Gulf War Veterans’ Illnesses 
implicate exposure to GW agents, such as the acetylcholinesterase (AChE) inhibitor pyridostigmine 
bromide (PB) and pesticides permethrin (PER), in the pathogenesis of GWI (White et al., 2016; Binns 
et al., 2008).  Evidence for a causal role of GW agents in GWI comes from studies showing elevated 
rates and severity of illness among veterans who consumed a large quantity of PB tablets and also 
applied pesticides (White et al., 2016; Binns et al., 2008; Steele et al., 2012).  A case-control study of 
300 GW veterans showed that compared to controls, veterans with GWI had a higher prevalence of 
exposure to PB and pesticides (White et al., 2016; Steele et al., 2012).  Given the CNS dysfunction in 
  
GWI, identifying molecular changes in the brain necessitates the use of well-established animal 
models of GWI.  We developed a GWI mouse model using combined exposure to PB and PER that 
exhibits anxiety and cognitive problems that are similar to the symptoms reported by veterans with 
GWI (White et al., 2016; Abdullah et al., 2011; Zakirova et al., 2015; Sullivan et al., 2003). Hence, this 
mouse model captures one of the key clinical features of GWI and is suitable for examining long-term 
changes that are relevant to the current clinical condition of veterans with GWI.  
 Histopathological analyses of this PB+PER mouse model revealed an increase in astroglia 
activation in exposed mice (Abdullah et al., 2011; Zakirova et al., 2015), which is also observed in 
several other rodent models of GWI (Abdullah et al., 2012; Abdullah et al., 2011; Zakirova et al., 
2015; Parihar et al., 2013; Ojo et al., 2014). In the brain, astroglia play a fundamental role in providing 
support to neurons by maintaining the extracellular environment and delivering nutrients to neurons 
that are acquired from the peripheral circulation. For instance, astroglia take up glucose from the 
brain capillaries via their end-feet and deliver to neuronal axons (Baltan 2015). While glucose is the 
primary energy source which fuels the tricarboxylic acid (TCA) cycle, other nutrients, such as ketone 
bodies and lactate, are used for neuroenergetics when the glucose supply runs low or during high 
neuronal demand (Logica et al., 2016). In the brain, β-oxidation of free fatty acids (FFA) yields acetyl-
CoA molecules for the TCA cycle to generate ATP (Guzmán, & Blázquez 2004). Importantly, astroglia 
are the primary cell type in the brain that can store glucose as glycogen which can be converted to 
lactate and transported to neurons via mono-carboxylate transporters (MCT) (Newington et al., 2013). 
In this regard, a recent imaging study showed impaired lactate utilization in the brains of veterans with 
GWI (Rayhan et al., 2013a), which could suggest potential disruption of the astroglia-neuron shuttle in 
relation to GWI.  
 The goal of this current work is to elucidate long-term biological disturbances associated with GW 
agent exposure. Several decades have now elapsed since veterans were exposed to GW agents, 
and, therefore, an interaction between exposure to these chemicals and aging is also a concern for 
  
this vulnerable population (Institute of Medicine 2013).  Given the complexity of biological response to 
GW agents, the heterogeneity of the clinical presentation of GWI and the chronicity of the illness 
(White et al., 2016), we used omic approaches (proteomics, lipidomics and metabolomics) to identify 
biological pathways associated with GW agent exposure.  These analyses pointed to mitochondrial 
lipid and energetic disruptions in our mouse model.  In a pilot study, we examined the translational 
value of mitochondria-specific lipids (acylcarnitines) in plasma and showed that these lipids have the 
potential to differentiate veterans with GWI from controls. Targeting mitochondrial lipid metabolism 
may be an avenue for developing treatments for the chronic and persistent CNS problems currently 
experienced by veterans with GWI.  These lipids may also be useful for identifying blood biomarkers 
of GWI.  
2. Materials and Methods: 
2.1. Animals 
 All animal experiments were approved by the Institutional Animal Care and Use Committee and 
performed as previously described (Abdullah et al., 2011; Zakirova et al., 2015).  Male C57BL6 mice 
(3-months of age, weight 25 g ± 0.7 SD) were co-administered 0.7 mg/kg of PB and 200 mg/kg of 
PER in a single intraperitoneal injection volume of 50 μl in dimethyl sulfoxide (DMSO) or the same 
volume of DMSO alone (control) daily for 10 consecutive days (n = 10 for controls, n = 9 for GW 
agent exposed mice).  The doses of PB and PER are less than 1/5 and 1/2 of the known LD50 values 
in rodents, respectively (Chaney et al., 2002; Williamson et al., 1989).  Given the paucity of 
information on doses and routes of PER exposure, we used 200 mg/kg of PER to mimic a high-level 
exposure that is similar to that used in mice by previous studies showing adverse behavioral or 
pathological outcomes (Abdullah et al., 2011; Zakirova et al., 2015; Dodd, & Klein 2009; Pittman et 
al., 2003). The cis/trans ratio of PER were based on the recommended by the World Health 
Organization (25% cis and 75% trans) (WHO 2003).  The dose of 0.7 mg/kg of PB have been shown 
to elicit neurobehavioral deficits relevant to GWI symptom presentation (Zakirova et al., 2015). 
  
Experimenters for neurobehavioral, neuropathological, lipidomics, metabolomics and proteomic 
analyses were blinded to the exposure assignment. For these studies, post-exposure time-points of 
15- and 16-months were chosen at which point these mice were 18- and 19-months of age, 
respectively.  
2.2. Human subjects 
 Plasma samples from 12 veterans with GWI and 8 healthy controls who were deployed to the GW 
were assessed in this pilot study.  Plasma samples from GW veterans were provided by our 
collaborators at the Boston University and NOVA Southeastern University sites from an established 
biorepository of samples from GW veterans who agreed to share their blood samples from prior 
studies including the Boston Gulf War Illness Consortium (GWIC) and the Dynamic Modeling of GWI 
study from NOVA Southeastern University and the South Florida Veterans Affairs Foundation for 
Research and Education, Inc. The GWI biorepository is approved by the institutional review board 
(IRB) at the Boston University, the NOVA Southeastern University and the Miami Veterans 
Administration Medical Center (VAMC).  Samples from the GWI biorepository were all collected from 
the Boston and Miami sites using the same written standard operating procedures for performing 
phlebotomy, plasma separation and aliquoting.   All samples were stored at -80oC and were not 
previously thawed and refrozen.  Gulf War veteran participants were consented into their respective 
studies using the International Conference on Harmonization Good Clinical Practice guidelines.  The 
Kansas GWI criteria (Steele 2000) were used to determine GWI case and control status.  The Kansas 
GWI criteria require that 1990-1991 GW veterans endorse symptoms in at least 3 out of 6 symptom 
domains (fatigue/sleep problems, pain, cognitive, mood symptoms, gastrointestinal symptoms, 
respiratory symptoms and skin abnormalities).  Controls veterans were also from the 1990-1991 GW 
who did not endorse 3 out of 6 symptom domains associated with the Kansas criteria.  Subjects also 
completed demographics and health symptom questionnaires including the Pittsburgh Sleep Quality 
Index (PSQI), Visual Analog Scale (VAS) for pain, Multi-dimensional Fatigue Inventory (MFI-20) 
  
questionnaire, Medical Outcome Study Short Form 36-veteran version (SF-36V), and Profile of Mood 
States (POMS). Study participants were excluded if they reported being diagnosed with another 
medical condition that could explain the above mentioned symptoms. According to the Kansas GWI 
case definition exclusions, veterans with a history of prior CNS or major psychiatric disorders that 
may affect cognitive function (e.g., epilepsy, stroke, brain tumor, multiple sclerosis, Parkinson’s 
Disease, Alzheimer’s disease, schizophrenia) would be ineligible.  For the purposes of current 
translational studies and due to the known interactions between GWI and gender (Abdullah et al., 
2012; Smylie et al., 2013), only male subjects were evaluated since the mouse studies were only 
comprised of male mice.  Both control GW veterans (n = 8) and veterans with GWI (n = 12) were 
matched for age (mean age in controls  = 49.3 ± 2.6 SE and GWI = 46.1 ± 1.6 SE) and ethnic 
background (among controls, 5 subjects were white, 1 Hispanic and 2 African American and among 
GWI, 4 subjects were white, 2 Hispanic, 5 African American and 3 Asian).  
2.3. Behavioral testing 
 The Barnes maze acquisition trials were conducted at 15-months post-exposure (daily over 4 
days) for 3 min per trial as previously described (Sunyer et al., 2007).  Briefly, four trials were 
administered per mouse with an inter-trial interval of 15 min.  Each mouse was placed in the middle of 
the maze and the trial ended when the mouse entered the escape box or after 3 min.  Bright flood 
lamps were used as motivators for mice to enter the escape box, where they stayed for 1 min.  If a 
mouse did not reach the target hole within 3 min, the experimenter guided it to the escape box.  A 
probe trial was conducted 24 hrs after the last training session.  The escape box was removed for the 
probe trials. Each mouse was placed in the middle of the maze and allowed to explore for a fixed 
interval of 1.5 min.  Another probe trial was administered at 16 months post-exposure to assess long-
term memory.  The Ethovision software was used to track mouse movement and total distance 
traveled by each mouse on the platform was used to calculate the path length.  Animals were 
subsequently euthanized for the neuropathological and biochemical studies. 
  
2.4. Neuropathological analyses 
 Animals were transcardially perfused with phosphate buffered saline (PBS) followed by an 
overnight fixation of the brains in 4% paraformaldehyde and embedded with paraffin. Sagittal sections 
(lateral 0.2-0.4mm) were prepared and rehydrated in an ethanol gradient before the staining 
procedures. Glial fibrillary acid protein (GFAP; 1:10,000, Dako, Carpinteria, CA, USA) and ionized 
calcium binding adaptor molecule 1 (Iba1) antibodies (1:5,000; Abcam, Cambridge, MA, USA) were 
used to stain astroglia and microglia, respectively. Primary antibodies were localized using Vectastain 
ABC kits (Vector Laboratories, Burlingame, CA, USA) as previously described (Abdullah et al., 2011; 
Mouzon et al., 2014).  ImagePro plus software (Media Cybernetics, Rockville, MD, USA) was used to 
analyze the stained sagittal sections (4 randomly selected non-overlapping areas of 100 μm2 of 
cerebral cortices and the dentate gyri). The stained areas were calculated and expressed as a 
percentage of the field of view.  
2.5 Proteomics 
Brain tissue was homogenized in PBS containing 1M sodium chloride (NaCl), and clarified 
by centrifugation.  The supernatant was fractionated into soluble and membrane fractions via 
methanolic PBS precipitation. Protein from 100µg of each sample underwent reduction and 
alkylation at cysteine residues to avoid self aggregation prior to trypsinization.  The digest was 
4-plex labeled using Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) according to 
manufacturer’s instructions (SCIEX, Framingham, MA, USA). The groups were paired and 
mixed according to experimental design and fractionated by reversed phase chromatography 
and analyzed by capillary liquid chromatography/mass spectrometry/mass spectrometry (LC-
MS/MS) using a Easy Ultra Performance Liquid Chromatography (UPLC) interfaced with a Q-
Exactive Orbitrap MS (Thermo). Higher-energy C-trap dissociation was used with the minimum 
m/z set to 100 to ensure the presence of the reporter ions in all MS2 spectra for quantification. 
Following quantification, differentially expressed proteins were investigated using Ingenuity 
  
Pathways Analysis (IPA, Ingenuity® Systems, Redwood City, CA, USA) (see supplementary 
methods for more details). 
2.6. Metabolomics 
 Brain homogenate from whole left hemisphere (50μl) containing 8mg wet weight of tissue were 
prepared as previously described (Abdullah et al., 2012) and combined with 5μl of deuterium (d) 
labeled internal standard (IS) mix containing 200 µg/ml d3-stearic acid and 5 µg/ml d5-phenylalanine 
and 200μl of 80% methanol. The mixture was heated for 2 min at 80oC and cooled for 5 min before 
centrifuging for 10 min at 20,000 x g. The supernatant was dried under vacuum and then aldehydes 
and ketones were derivatized to their methoximes by addition of 10 µl of methoxylamine 
hydrochloride in pyridine and heating at 30oC for 90 min. Functional groups containing active 
hydrogen were converted to their trimethylsilyl derivatives by addition of 90 µl of N-Methyl-N-
trimethylsilyltrifluoroacetamide containing 1% trimethylchlorosilane followed by incubation at 60oC for 
30 min. Derivatized samples were analyzed on Agilent 7200 GC-QTOF (Agilent, Santa Clara, CA, 
USA). One μl of sample was injected (split 1:10, injector temperature 250oC and hydrogen as the 
carrier gas) onto a DB5-MS column (30 m X 0.25 mm ID, 0.25 µm film thickness). The column 
temperature was held at 60oC for 1 min and then programmed to 325oC at 10oC/min with a 3.5 min 
final hold.  Electron impact ionization (EI) was used at 70 eV with the source at 250oC. Spectra were 
acquired from m/z 40 – 600 at the rate of 5 spectra/second, mass accuracy <2 ppm and mass 
resolution greater than 13,500 full width at half maximum (FWHM).  Metabolites were identified by 
searching spectra from our dataset with those deposited in the Golm database (http://gmd.mpimp-
golm.mpg.de/) and the Fiehn gas chromatography/mass spectrometry (GC/MS) metabolomics 
retention time locked library (Agilent Technologies, created 21 Jul 2013).  Spectra were exported and 
normalized against d5-phenyalanine for amino acids and d3-stearic for all other metabolites) followed 
by statistical analyses using SPSS version 22 (IBM Corporation, Armonk, NY, USA). 
2.7. Lipidomics 
  
 Brain homogenates for lipidomics were prepared as for metabolomics studies described above.  
Cardiolipin analysis:  Cardiolipin (CL) extraction was carried out using modified Bligh-Dyer method 
described elsewhere and in the supplemental section (Sparagna et al., 2005). The lower organic 
phase was collected and dried for liquid chromatography/mass spectrometry (LC/MS) analysis. 
Normal phase high-pressure liquid chromatography (HPLC) was carried out using a 1 mm ID x 100 
mm column containing 3 μm Ultra silica particles (Restek, Bellefonte, PA, USA).  A gradient was run 
from 50% solvent B (isopropanol: hexane 40:30 v/v) in solvent A (isopropanol:hexane:20mM 
ammonium acetate 40:30:7 v/v/v) to 95% B in 14 min with a 6 min hold at the final conditions. The 
flow rate was 50 μl/min with the column temperature at 40°C.  Negative ion electrospray spectra were 
acquired at 100,000 resolution with a scan range from m/z 590 to 900 on a LTQ-Orbitrap mass 
spectrometer (Thermo Scientific, Waltham, MA, USA).  All spectra were obtained with a 200 ms 
maximum ion injection time. The acquired spectra of doubly-charged ions corresponding to individual 
CL species were deconvoluted (converted to an uncharged spectra) and deisotoped using the Xtract 
utility in the Xcalibur software (Thermo Scientific, Waltham, MA USA) and quantified with reference to 
the internal standard. Determination of FA composition of individual CL species is based on reported 
literature (Monteiro-Cardoso et al., 2015).  
 Acylcarnitine analyses:  Aclycarnitine was extracted from 50μl of brain homogenate or 50μl of 
plasma to which 5μl of labeled internal standard mix (Nsk-b-1, Cambridge isotope laboratories, MA, 
USA) was added with 500μl of 25% methanol in acetonitrile (ACN) followed by centrifugation at 
20,000 x g.  Dried extracts were resuspended in 5% aqueous methanol and subjected to LC/MS 
using a 2.1mm ID x 50mm Kinetex HILIC column containing 1.7 μm particles (Phenomenex, 
Torrance, CA, USA).  A gradient was run from 95% solvent A (ACN:water:100mM ammonium 
formate,90:5:5 v/v) in 5% solvent B (ACN:water:100mM ammonium formate,50:45:5 v/v) to 70% B in 
10 min with a 10 min hold at the final conditions. The flow rate was 250 μl/min with the column 
temperature at 40°C. Positive ion electrospray spectra was acquired in the FTMS mode at 30,000 
  
resolution with a scan range from m/z 150 to 1000 on a LTQ-Orbitrap MS (Thermo Scientific).  All 
spectra were obtained with a 100 ms maximum ion injection time and summing 2 microscans. 
  Phospholipid analyses: Lipids were extracted from mouse brain homogenates and plasma using 
the Folch method (Folch et al., 1957). Internal standards for each phospholipid (PL) class were added 
to control for technical variability and for quantification, see procedures elsewhere (Abdullah et al., 
2014). Phospholipids were separated using normal phase LC/MS with a Thermo LTQ-XL mass 
spectrometer (Thermo-Fisher, MI, USA) as previously described (Abdullah et al., 2014).  Mass 
spectra were processed using LipidomeDB online to identify and quantify PL molecular species (Zhou 
et al., 2011). Within each class, the molecular species that were identified were totaled to generate 
total phosphatidylcholine (PC), phosphatidylethanolamine (PE), sphingomyelin (SM) and 
phosphatidylinositol (PI) values. 
 Total Fatty acids: Brain homogenate prepared as above was combined with 14:0 and 17:0 fatty 
acid (FA) as internal standards, extracted using the Folch method (Folch et al., 1957) and total FA 
were prepared followed by saponification of lipids and followed by preparation of methyl esters of 
these FA (see supplemental section for more details). The fatty acid methyl esters were dissolved in 
isooctane for GC/MS analysis using an Agilent 5975 Turbo GC/MS system (Agilent, Wilmington, DE 
USA).  An Agilent HP-88 Fused Silica Capillary column 30 m x 250 μm x 0.20 μm film thickness was 
used with hydrogen as the carrier gas using a splittless injection. The GC oven temperature was held 
at 70°C for 3 min, increased at a rate of 100°C per min up to 140°C then programmed at a rate of 3°C 
per min up to 210°C. MS was performed with positive ion ammonia chemical ionization and spectra 
acquired from m/z 200 – 440. 
2.8. Statistical analyses  
 If data were normally distributed (based on the histogram plots and skewness/kurtosis measures), 
a mixed linear model (MLM) regression was employed to examine the independent effects of 
exposure and time and any potential interactions between them on the neurobehavioral outcomes.  
  
As applicable, skewed data were either normalized using log transformation for MLM or analyzed 
using generalized estimating equation (GEE) to test the statistical significance of skewed data and p-
values were calculated using the Wald test. For neurobehavioral studies, the total path length to the 
target hole was considered an outcome factor where exposure, acquisition days and trials were 
considered fixed factors and each mouse was a random factor. Neuropathology data were analyzed 
using the MLM or GEE depending on the distribution of the dataset where exposure and replicates 
were fixed factors and mouse was a random factor. For lipidomics, principal component analysis 
(PCA) were performed to achieve the dimension reduction and minimize multi-colinearity followed by 
MLM regression as previously described (Abdullah et al., 2012; Graessler et al., 2009).  Variables 
with eigenvalues of >1 were retained, PCA was used for extracting components, and varimax with 
Kaiser normalization was used for generating linear combinations to maximize variance loading in 
order to simplify and clarify the data structure. The Anderson–Rubin method was used for exporting 
uncorrelated scores in order to perform MLM regression analyses on each component and the 
outcome measures, while adjusting for fixed (exposure and replication) and random factors (mouse). 
Metabolomics data were analyzed using MLM with fixed factor being exposure and replication and 
random factor being mouse.  
3.0. Results: 
3.1. Neurobehavioral deficits accompany brain mitochondrial disturbances in GW-agent exposed 
mice. 
We observed neurobehavioral deficits in the Barnes Maze test at 15- and 16-months post-
exposure.  During the acquisition trials conducted at 15-months post-exposure, mice were allowed to 
explore the arena for 3 min and escape into the visible box through one of the holes in the circular 
platform.  Control mice learned to escape, which corresponded with a significantly shorter path length 
over training days 1 through 4. However, GW agent exposed mice had similar path length throughout 
the training period.  During the probe trials, conducted on day 5 at 15-months post-exposure and 
  
another 30 days later at 16-months post-exposure (without retraining), the visible escape box was 
removed and each mouse was allowed to explore the arena for 1.5 min.  At both trials, exposed mice 
had longer path length than controls indicating poor spatial memory (Fig. 1A-B).  Neuropathological 
analyses show small but significant astroglia and microglia activation within the dentate gyri of 
exposed animals at 16-months post-exposure (Fig. 1C-N).  There were no differences between the 
two groups for astroglia and microglia activation within the cortices or other hippocampal regions. 
Differentially expressed proteins from the proteomic studies were uploaded into the IPA 
knowledgebase. Biological functions (biofunctions), such as lipid metabolism, energy production, cell 
cycle, molecular transport, inflammatory responses and immune cell trafficking were shown to be 
modulated at 16-months post-exposure to GW agents. Glycolysis I, sucrose degradation V and 
gluconeogenesis I were the three most modulated canonical pathways following GW agent exposure 
(Fig. 2). Additional canonical pathways affected by GW agents included, mitochondria dysfunction, 
pyruvate fermentation to lactate and creatine phosphate biosynthesis.  Metabolomic data (Fig. 3) also 
supported mitochondria dysfunction by showing that lactate, β-hydroxybutyrate (β-HB) and the Krebs 
cycle metabolites, such as succinic acid, fumaric acid, malic acid, citric acid and isocitric acid were 
significantly lower in exposed mice compared to controls.  Glycerol-3-phosphate and glyceric acid 3-
phosphate were also lower in exposed mice (p < 0.05). 
 
3.2. Long-term decreases in brain lipids in GW agent exposed mice. 
Lipidomic analyses were performed to examine mitochondria specific lipids, CL and acylcarnitines.  
Relative to control mice, exposed mice had lower levels of CL, particularly long-chain unsaturated 
species (Fig. 4A).  Long-chain acylcarnitine species (Fig. 4B) were also decreased in the brains of 
GW agent exposed mice compared to control mice (p < 0.05).  Significant decreases in PE, PC, PI, 
and LPC were also observed in exposed mice compared to controls (Fig. 4C).  Supplemental figure 1 
shows the molecular species distribution for each PL class associated with GW agent exposure; a 
  
number of these were essential polyunsaturated fatty acid (PUFA) containing molecular species.  
Total fatty acid (FA) analysis (Fig. 4D) showed decreases in omega-3 and omega-6 PUFA (p < 0.05), 
where most substantial decreases were observed in omega-3 docosahexaenoic acid (DHA, 22:6n3) 
and omega-6 arachidonic acid (AA, 20:4n6) and adrenic acid (22:4n6). 
3.3. Plasma acylcarnitines alterations in GW-agent exposed mice and GWI veterans 
Acylcarnitines are the most abundant mitochondrial lipids that are present in appreciable 
quantities in plasma.  We examined whether these lipids were also altered in plasma samples from 
our mouse model and in male GW veterans with GWI (46.1 ± 0.92 SE years) compared to male 
control GW veterans (49.3 ± 1.43 SE years). Figure 5 shows the distribution of acylcarnitine species 
in plasma from control and exposed mice at 16-months post-exposure.  While short-chain (< 6 
carbons) acylcarnitine species did not differ between control and exposed mice, odd-chain species (3, 
5 and 7) were increased, whereas medium- (6 to 12) and long-chain (14 to 20) acylcarnitine species 
were decreased in GW agent exposed compared to control mice (p < 0.05).  In human plasma, we 
observed an increase in odd-chain (p < 0.05) and a trend for decrease in long-chain acylcarnitines in 
veterans with GWI compared to control veterans (p = 0.08).  We also detected very long-chain 
acylcarnitine species (C24:0 to C26:0) and found these species to be also decreased in veterans with 
GWI compared to controls (p < 0.05).  Figure 6 shows the distribution of acylcarnitine species in 
veterans with GWI and in healthy controls.  There were no differences between GWI and control 
subjects for short-chain and medium-chain acylcarnitine species (data not shown).  
4.0 Discussion:  
 To date, GWI remains difficult to diagnose and there are no effective treatments that target the 
underlying pathology.  Given the prominent CNS component to this illness, the use of animal models 
is necessary for molecular characterization of the brain in order to identify biological targets for 
treating GWI.  Owing to the complexity of biological responses to GW agents and a heterogeneous 
presentation of clinical symptoms in patients, it has been challenging to identify molecular targets for 
  
therapeutic intervention.  Our omic analyses presented herein point to long-term mitochondrial lipid 
and bioenergetic disturbances following subacute exposure to GW agents. The internal consistency 
of these findings is demonstrated in proteomic data showing disruption of pathways which regulate 
mitochondrial bioenergetics, metabolomics data showing changes in mitochondrial metabolites 
corresponding with these pathways and lipidomics data showing decreases in several classes of 
lipids that are specific to mitochondria in exposed mice. These GW-agent induced long-term 
mitochondria disturbances are accompanied with astroglia and microglia activation in the 
hippocampus and coincide with impaired learning and spatial memory.  We also show that 
mitochondria specific lipids are altered in plasma from this GWI mouse model and in veterans with 
GWI. As such, these lipids, with further validation, could be useful as translational biomarkers of GWI.  
Collectively, these studies suggest that mitochondria lipid disturbances in GW agent exposed mice 
are also present in veterans with GWI and may be associated with long-term consequence of GW 
agent exposure that are relevant to current clinical status of GWI.   
 Cognitive deficits are among the most common complaints in veterans with GWI with affected 
veterans performing poorly on neuropsychological tests in tasks relating to executive functioning and 
memory compared to controls (Sullivan et al., 2003; Anger et al., 1999; Sillanpaa et al., 1997; Binder 
et al., 1999; Bunegin et al., 2001; Lange et al., 2001; Storzbach et al., 2000).  Using a GWI mouse 
model, we demonstrate that cognitive deficits are present at 16-months post-exposure in mice 
exposed to GW agents at an early age.  Despite being 18-months of age, the path length for control 
mice improved significantly over the training period while GW agent exposed mice of same age had 
similar performance throughout the training, suggesting impaired learning in exposed mice.  Gulf War 
agent exposed mice exhibited persistent spatial memory deficits on probe trials conducted at 15- and 
16-months post-exposure, having longer path length than control mice.  Our studies are consistent 
with previous studies in showing that cognitive impairment is a persistent feature of GWI as observed 
  
in rodent models of GWI (Abdullah et al., 2011; Zakirova et al., 2015; Abdullah et al., 2012; Parihar et 
al., 2013; Terry 2012).  
 Accompanying neuropathology in this mouse model included the presence of activated astroglia 
and microglia in the hippocampi of exposed mice relative to controls. Glial cells perform a variety of 
functions in the brain including immune surveillance and maintenance of energy homeostasis, 
dysregulation of which is thought to propagate age related cognitive dysfunction (Bilbo et al., 2012).  
Brain inflammation, as determined by increases in pro-inflammatory cytokines and microglia 
activation, is supported by studies in other rodent models of GWI (Parihar et al., 2013; O'Callaghan et 
al., 2015).  This is consistent with clinical studies showing altered pro-inflammatory cytokines in 
veterans with GWI relative to controls (Skowera et al., 2004; Whistler et al., 2009; Broderick et al., 
2013; Parkitny et al., 2015).  Astroglia are key regulators of the nutrient supply to the brain, converting 
FA to β-HB, which serves as an energy source when the glucose supply is low or during high 
neuronal activity (Guzmán, & Blázquez 2004).  Astroglia produce lactate through glycolysis, which is 
then transported to neurons via specialized MCT and serves as an alternative fuel for ATP production 
in neurons (Stobart, & Anderson 2013; Rayhan et al., 2013b).  A small case-control functional 
magnetic resonance (fMRI) imaging study showed uncoupling of lactate utilization and glutamate to 
glutamine conversion during exercise in a subset of veterans with GWI, which could suggest 
deregulation of the astroglia-neuron lactate shuttle could potentially be associated with CNS 
bioenergetic disturbances in GWI (Rayhan et al., 2013a).  In agreement with this, our proteomic 
studies identified that GW agent exposure was associated with bioenergetics, particularly pathways 
related to conversion of pyruvate to lactate and gluconeogenesis.  These findings were confirmed by 
metabolomic studies showing a reduction of the Krebs cycle metabolites, lactate, pyruvate, β-HB and 
glycerol phosphates in the brains of GW agent exposed mice. 
 We observed that CL, a key mitochondrial lipid, is dramatically reduced in the brains of GW agent 
exposed mice. Cardiolipin represents 20% of total mitochondrial lipids (Horvath et al., 2015) and a 
  
reduction in CL is a strong indicator of decreased activity of the electron transport chain (ETC) (Shen 
et al., 2015).  Mitochondrial bioenergetics rely on adequate quantities of CL and a reduction of CL 
suggests impaired ATP production.  Studies have shown that exposure to certain pesticides lowers 
CL in different brain regions (Astiz et al., 2009; Czerniczyniec et al., 2013).  There is some evidence 
that mitochondrial disturbances might be present in veterans with GWI. A small matched case-control 
study of 31Phosphorus Magnetic Resonance Spectroscopy showed that veterans with GWI had 
prolonged post-exercise recovery of muscle phosphocreatine following exercise compared to 
controls, suggesting defective energy metabolism in the mitochondria (Koslik et al., 2014).  As 
mentioned above, a fMRI study showed impaired lactate utilization as an alternative energy supply in 
the brains of veterans with GWI (Rayhan et al., 2013a).  Support for a possible association of 
mitochondria dysfunction in GWI also comes from animal studies. In rats, chronic exposure to an 
organophosphate (OP) pesticide dichlorvos was associated with increased mitochondrial reactive 
oxygen species production, decreased manganese superoxide dismutase activity and increased lipid 
peroxidation (Binukumar et al., 2010). Dynamic measurements of mitochondria following chlorpyrifos 
exposure showed impaired mitochondrial electron transport and decreases in mitochondrial length, 
number and axonal movement in rodents exposed to GW agents (Binukumar et al., 2010; 
Middlemore-Risher et al., 2011). 
 In addition to CL, mitochondria contain PC, PE, and PI where PC and PE together comprise 60% 
and PI comprise 10% of total mitochondrial PL (Mejia, & Hatch 2016).  Acylglycerophosphate 
acyltransferase 4 (AGPAT4) is abundant in the brain and resides in the outer mitochondria membrane  
(Bradley et al., 2015).  Although AGPAT4 catalyzes the formation of phosphatidic acid (PA), this 
reaction is a branching point for the Kennedy pathway, regulating conversion of PC from methylation 
of PE.  As such, this enzyme has the potential to alter the composition of PL classes within the 
mitochondria.  In fact, a recent in vivo study demonstrated that loss of this enzyme resulted in 
decrease in PC, PE and PI (Bradley et al., 2015). Since we also observe decreases in these PL 
  
classes in the brains of GW agent exposed mice, interrogation of lipid metabolism by AGPAT4 may 
assist in understanding of the pathophysiology of GWI. 
 Acylcarnitines transport FA to the mitochondrial inner membrane for β-oxidation and maintain the 
balance between the free and esterified CoA (Corso et al., 2011).  Acylcarnitines have been proposed 
as biomarkers of metabolic disorders (i.e. diabetes), disorders caused by environmental exposures 
and neurodegenerative diseases (De Palo et al., 1981; Mihalik et al., 2010; McGill et al., 2014).  
Therefore, we examined their levels in plasma from our GWI mouse model and veterans with GWI 
compared to their respective controls.  Odd-chain acylcarnitines were elevated in GW agent exposed 
and in veterans with GWI relative to their respective controls.  There were no differences in the brain 
concentrations of odd-chain acylcarnitines between control and exposed mice.  As such, plasma 
changes in these acylcarnitines suggest that these effects are peripheral rather than CNS 
manifestation of this illness.  An elevation of odd-chain acylcarnitines in plasma is indicative of 
methylmalonyl-CoA mutase deficiencies (Jones et al., 2010), a mitochondrial enzyme which is a part 
of the metabolic pathways that catabolize certain amino acids, odd-chain fatty acids and cholesterol 
to generate metabolites for the Krebs cycle (Hörster, & Hoffmann 2004). Deficiencies of this enzyme 
are shown to accompany mild brain edema in a few case studies (Lee et al., 2008).  We only 
detected even carbon long-chain and very long-chain acylcarnitines in plasma.  Long-chain 
acylcarnitines were generally decreased in both the brain and plasma of exposed mice and 
decreased in plasma from veterans with GWI.  We were unable to detect very long-chain 
acylcarnitines in mice but these species were detectable in human plasma and were lower in 
veterans with GWI compared to controls.  Together, decreases in long-chain and very long-chain 
acylcarnitines suggest acetyl-CoA shortage or impaired activity of enzymes that catalyze transfer of 
the acetyl group from CoA to carnitine  (van Vlies et al., 2005).  Hence, confirmatory analyses in 
larger cohorts of GW veterans are required to better understand the biological relevance of the 
  
carnitine shuttle in the pathobiology of GWI and to determine if plasma acylcarnitine levels could 
potentially serve as biomarkers of GWI.   
5.0 Conclusion: 
 Gulf War Illness is primarily characterized by symptoms of fatigue, joint pain and impaired 
cognition. Among the multisymptom presentation of GWI, memory impairment represents one of the 
most common and debilitating symptoms (White et al., 2016; Smith et al., 2013; Binns et al., 2008).  
We observed mitochondrial lipid disturbances in a well-validated GWI mouse model exhibiting glia 
activation which corresponded with a functional outcome of neurobehavioral deficits long after 
subacute exposure to GW agents indicating the chronic nature of the effects.  In addition, we provide 
pilot evidence that mitochondrial lipid alterations are also present in veterans with GWI.  Hence, this 
mouse model displays both cognitive impairment and mitochondrial lipid defects seen in veterans with 
GWI.  Although considerable work remains to determine if mitochondria dysfunction has an important 
pathological role in GWI, these studies indicate further investigation of mitochondrial function could 
provide a better understanding of the pathobiology of GWI. These studies also suggest that targeting 
mitochondria lipid metabolism may lead to therapies for treating the symptoms of GWI. 
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Figure 1: The neurobehavioral and neuropathological deficits in GW agent exposed mice at 
16-months post-exposure. Barnes Maze: (A) Mean ± SEM in control (n = 10) and exposed mice (n 
= 9).  The total path length to the target hole was shorter for controls vs. exposed mice and there was 
an overall interaction between exposure and trials for all of the training period during the acquisition 
trials (p < 0.05). Post-hoc analyses for each training day showed that the interactions between trials 
and exposure were significant for days 1, 2 and 4 only, *p < 0.05.  (B) For the probe trials at 15- and 
16-months post-exposure, larger path length for exposed mice compared to controls is indicative of 
spatial memory deficits. Post-hoc analyses showed a significant net decrease in exposed mice 
relative to controls at 15- months (*p < 0.05) and p = 0.051 for 16-months post-exposure. (C-H) 
Sagittal sections 0.4 mm lateral to midline in the layer III/IV of the cortex. Staining of astroglia with 
GFAP and (I-N) microglia with iba1. (C-E) There were no differences between the groups for GFAP 
within the cortex.  (E-F) Compared to controls, exposed mice had 1.7 fold increase in GFAP in the 
DG, *p < 0.05. (F) The arrow points to an activated astroglia with highly branched processes and 
hypertrophied cell body. The insert shows an example of activated astroglia. (I-J) There were no 
differences between the two groups for iba1 in the cortex. (K-L) Iba1 staining in DG was 1.2 fold 
higher in exposed vs. controls.  The arrows point to activated microglia cell with hypertrophic cell 
body,*p < 0.05. The insert shows an example of activated microglia. 
 
Figure 2. Ingenuity Pathway Analysis (IPA) identified networks, biofunctions and canonical 
pathways modulated by GW agent exposure: Brain proteins that were differentially expressed at 
16-months post-exposure to GW agents were interrogated using IPA.  (A) Differentially expressed 
proteins were further interrogated using IPA, and a ‘‘Core Analysis’’ was performed, termed  
biofunctions. The blue bars represent biological functions that were significantly modulated by GW 
exposures. The red line designated by the term “threshold” indicates the statistical significance cut-off 
  
of -log(p-value) 1.5 (based on right-sided Fishers exact test).  Lipid metabolism, immune cell 
trafficking, energy production and molecular transport were affected by GW agent exposure.  (B) 
Canonical pathways (gray bars) most significant to the dataset were determined based on the ratio 
(exhibited as solid black line with dots) of the number of proteins mapping to a particular pathway 
divided by total number of proteins significantly modulated by GW agent exposure. A right-sided 
Fishers exact test to calculate a p value (line named threshold indicating the statistical cut-off of -log 
(p-value) 1.5).  Canonical pathways included glycolysis, gluconeogenesis, glycerol-3-phosphate 
shuttle and mitochondria dysfunction were associated with GW agent exposure. 
 
Figure 3: Metabolomic analyses showing decreases in lipid metabolites, lactate, the Krebs 
cycle compounds and glycerol phosphate following GW agent exposure. Mean ± SEM 
(expressed as percentage of control, n = 4 per group).  (A) Metabolites within the TCA cycle, (B) 
lactate, β-HB, (C) glycerol-3-phosphate, glycerol-2-phosphate and glyceric acid phosphate were all 
decreased in exposed relative to control mice. *p < 0.05, **p < 0.01. 
 
Figure 4. Brain lipid profiles show significant decreases in cardiolipin, phospholipids, 
acylcarnitines and total fatty acids in GW agent exposed mice relative to controls. Mean ± SEM 
(expressed as percentage of control, n = 4 per group). (A) While most CL species were decreased in 
exposed mice compared to controls, those with highly unsaturated double-bonds were the lowest 
following GW exposure. (B) Several long chain acylcarnitine species were decreased in GW agent 
exposed mice. (C) Individual molecular species for each PL class identified by LC/MS were summed 
after lipidomeDB analyses to calculate total PL levels within each class. Relative to controls, PC and 
LPC were 8% lower, whereas total PE was 16% and total PI was 18% lower in exposed mice. (D) 
Major omega-3 fatty acids that are highly enriched in the brain, such as omega-3 DPA (22:5n3) and 
  
DHA (22:6n3) and omega-6 AA (20:4n6) and adrenal acid (22:4n6) were decreased in GW agent 
exposed mice than controls.*p < 0.05, **p < 0.01. 
 
Figure 5. Plasma acylcarnitine profiles in GW agent exposed mice relative to controls. 
Mean ± SEM (expressed as percentage of control, n = 4 per group). (A) odd-chain acylcarnitine 
species were increased while (B) medium, and (C) long-chain acylcarnitine species were decreased 
in exposed mice compared to controls. (D) Individual molecular species of acylcarnitine that were 
significantly increased after PCA followed by MLM analyses.  Odd-chain C3:0 and C5:0 were 
significantly elevated in exposed animals but the remaining species were decreased in the GW agent 
exposed mice compared to control mice.*p < 0.05,**p < 0.01 
 
Figure 6. Plasma acylcarnitine profiles in veterans with GWI compared to GW control veterans.  
Mean ± SEM (n = 8 for controls and n = 12 for GWI). (A) odd-chain acylcarnitine species were 
increased while (B) long-, and (C) very long-chain acylcarnitine species were decreased in veterans 
with GWI compared to controls. (D) Individual molecular species of acylcarnitine examined with PCA 
followed by MLM analyses.  C18:0, C18:3 and C26:0 were marginally significant (p = 0.06, p = 0.09 
and p = 0.09, respectively).  The remaining long- and very-long chain species were significant at p < 
0.05. Odd-chain C3:0 was not identified as part of the PCA associated with GWI but significantly 
elevated in veterans with GWI compared to controls (p = 0.05). 
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